Latest / Morning Medical with Dr. Chow / U.S. and WHO Relations, Diversity in Medicine, and Weight Loss Medications

Transcript

U.S. and WHO Relations, Diversity in Medicine, and Weight Loss Medications · Morning Medical with Dr. Chow

0:00
Good morning and welcome to Morning Medical with Dr.
0:02
Chow.
0:03
I'm your host, Dr.
0:04
Chi-Ming Chow.
0:05
Today, we're diving into a significant global health issue that's been making waves recently
0:10
– the United States' relationship with the World Health Organization, or WHO.
0:16
Specifically, we'll assess former President Trump's claim that the U.S.
0:20
pays an 'unfair' share of dues to this essential global health body.
0:28
Recently, President Trump signed an executive order to withdraw the United States from the
0:32
World Health Organization.
0:34
This decision has raised eyebrows across the global health community, given the vital role
0:39
WHO plays in international health cooperation.
0:42
Trump justified the move by pointing out what he considers an imbalance in financial
0:48
contributions between the U.S.
0:49
and China.
0:51
According to Trump, the U.S.
0:52
pays five hundred million dollars annually to WHO, while China contributes only thirty-nine
0:59
million dollars.
1:01
He questioned whether this disparity was just, especially considering China's population is
1:07
significantly larger than that of the U.S.
1:11
To understand this claim better, let's look at how WHO funding actually works.
1:15
The organization is financed through two primary streams.
1:19
First, there are assessed contributions from its nearly two hundred member states.
1:24
These contributions are calculated based on a country's capacity to pay, which considers both
1:29
population size and economic strength.
1:33
For 2024 to 2025, the U.S.
1:36
was assessed to contribute two hundred sixty-four million dollars, while China's
1:40
contribution was set at one hundred eighty-one million dollars.
1:45
This means the assessed contributions do not reflect as large a discrepancy as Trump's claim
1:51
suggests.
1:53
The second, and larger, pool of funding comes from voluntary contributions.
1:59
This includes donations from member states, philanthropic foundations, corporations, and
2:06
private citizens.
2:08
During the same period, the U.S.
2:10
was projected to provide four hundred forty-two million dollars in voluntary contributions,
2:16
compared to China's two and a half million dollars.
2:19
When combining both assessed and voluntary contributions, the U.S.
2:23
was on track to pay seven hundred six million dollars, while China was set to contribute one
2:29
hundred eighty-four million dollars.
2:32
Trump's figures did highlight a difference, but his comparison was not entirely accurate.
2:37
If we consider both types of contributions, China's contribution is closer to twenty-six
2:42
percent of what the U.S.
2:44
pays, rather than the eight percent Trump suggested.
2:48
Beyond the numbers, the potential withdrawal of the U.S.
2:51
from WHO sends a powerful message.
2:55
It could be perceived as an attack on international health cooperation by one of the
2:59
world's most powerful nations.
3:02
Experts like David McCoy from the United Nations University International Institute for
3:07
Global Health emphasize that such cooperation is crucial for managing pandemics and other
3:13
cross-border health threats.
3:15
WHO itself has expressed regret over the U.S.'s decision, hoping for a reconsideration to
3:22
maintain this vital partnership.
3:25
The financial implications of the U.S.
3:27
withdrawal could have significant consequences, particularly for low- and middle-income
3:31
countries that rely heavily on WHO's support.
3:36
Andrew Harmer, a global health policy researcher, notes that these countries often
3:41
face a disproportionate share of conflicts and disasters.
3:45
For WHO, losing a substantial part of its budget could mean having to adjust its
3:50
operations and priorities, potentially impacting global health initiatives.
3:56
It's important to recognize that WHO's funding for 2025 is already secured, including
4:02
contributions from the U.S.
4:04
However, the real challenge will come in 2026, when WHO may need to navigate a reduced budget
4:10
if the U.S.
4:11
withdrawal proceeds as planned.
4:14
This situation underscores the importance of safeguarding WHO's responsibilities to promote
4:20
and protect public health from the political tensions that can arise between member
4:25
countries.
4:28
The Trump administration has recently implemented a significant pause on
4:32
communications from several federal health agencies in the United States, which is set to
4:36
last through at least the end of January.
4:39
This freeze affects a wide range of communications, including regulations,
4:44
guidance, announcements, news releases, social media posts, and website updates.
4:50
The directive was communicated through a memo from Dorothy Fink, the acting secretary of the
4:55
U.S.
4:55
Department of Health and Human Services, stating that these communications would need
4:59
approval from a political appointee before being released.
5:03
This pause also impacts publications intended for the Federal Register and the Morbidity and
5:08
Mortality Weekly Report, a scientific journal published by the Centers for Disease Control
5:13
and Prevention.
5:15
The agencies affected by this directive include the Centers for Disease Control and Prevention,
5:20
the National Institutes of Health, and the Food and Drug Administration.
5:25
These are pivotal institutions involved in epidemic management, food safety, and disease
5:31
research.
5:32
It's not uncommon for new administrations to pause agency communications to ensure alignment
5:38
with their priorities, as noted by Steven Grossman, a consultant for food and drug
5:42
companies.
5:43
However, this move has raised concerns among public health experts who worry it might signal
5:49
a return to previous attempts to control public health narratives, particularly those that
5:54
conflict with the administration's messaging.
5:58
Dr.
5:59
Ali Khan, a former outbreak investigator for the Centers for Disease Control and Prevention,
6:05
suggested that while coordination is essential during transitions, the concern lies in whether
6:11
this is a prelude to restricting agencies' communication around political narratives.
6:17
This echoes past efforts during Trump's first term, where political appointees sought to
6:22
influence the Centers for Disease Control and Prevention's journal publications.
6:29
The pause has sparked criticism from consumer advocacy groups and public health experts who
6:35
emphasize the importance of timely information from federal health agencies.
6:40
Dr.
6:40
Peter Lurie, president of the Center for Science in the Public Interest, warned that any
6:46
delay in publishing urgent public alerts during active outbreaks could threaten public safety.
6:52
He stressed that timely information is crucial for preventing foodborne illnesses and other
6:57
health issues.
6:59
Dr.
6:59
Jeffrey Klausner from the University of Southern California echoed these concerns,
7:04
highlighting that local health officials and doctors rely on timely updates from the Centers
7:09
for Disease Control and Prevention for disease management, prevention, and treatment
7:15
guidelines.
7:16
He likened the communication freeze to shutting down essential public health functions,
7:21
comparing it to turning off fire sirens during emergencies.
7:27
The medical profession, much like many other fields, has long grappled with issues of
7:32
diversity and representation.
7:35
However, recent studies and expert commentaries have pointed out that diversifying the medical
7:40
profession not only addresses social equity but also significantly enhances health outcomes for
7:47
all communities.
7:48
This is a topic that has been gaining traction, with healthcare leaders and educational
7:53
institutions advocating for more inclusive practices.
7:57
Dr.
7:58
Ngozi Ezike, president and chief executive officer of Sinai Chicago, and Steve Beard,
8:04
chairman and chief executive officer of Adtalem Global Education, recently highlighted the
8:09
urgent need for diversity in medicine.
8:12
They argue that a more diverse medical workforce can bridge gaps in healthcare
8:16
delivery and improve patient trust and satisfaction.
8:21
When patients see healthcare providers who understand their cultural backgrounds and speak
8:25
their language, communication is enhanced, and care becomes more personalized and effective.
8:32
Ezike and Beard emphasize that diversity in the medical field is not just about increasing
8:37
numbers but about fostering an environment where diverse perspectives are valued and
8:42
integrated into healthcare practices.
8:45
This approach can lead to more innovative solutions to health challenges and better
8:50
health policies that consider the needs of all populations.
8:54
For instance, diverse teams are more likely to recognize and address health disparities that
9:00
disproportionately affect minority communities.
9:04
Furthermore, studies have shown that patients tend to have better health outcomes when
9:09
treated by healthcare providers who share their racial or ethnic background.
9:13
This is particularly evident in preventive care and chronic disease management, where
9:19
understanding and trust play a crucial role.
9:24
A diverse medical workforce can also contribute to more comprehensive medical research that
9:29
includes underrepresented groups, leading to findings that are more applicable to the
9:33
general population.
9:35
Educational institutions play a critical role in this effort by actively recruiting and
9:41
supporting students from diverse backgrounds.
9:44
Programs that provide mentorship, scholarships, and resources to minority students can help
9:50
break down barriers to entering the medical profession.
9:54
By fostering a more inclusive environment, these institutions are helping to prepare a new
9:59
generation of healthcare professionals who are equipped to serve a diverse and global
10:05
community.
10:07
In conclusion, the push for diversity in the medical profession is not just a moral
10:12
imperative but a practical one.
10:15
It is a step towards a more equitable healthcare system that benefits everyone.
10:20
As we continue to navigate the complexities of global health challenges, a diverse medical
10:25
workforce will be instrumental in ensuring that healthcare is accessible, effective, and
10:30
compassionate for all.
10:33
Today, we're delving into the intriguing world of weight loss medications, specifically
10:39
focusing on Ozempic and similar drugs.
10:42
These medications, which include well-known names like Wegovy, Mounjaro, and Zepbound,
10:48
belong to a class called glucagon-like peptide-1 agonists, or GLP-1 drugs.
10:54
Originally developed to treat diabetes, these drugs have gained popularity for their
10:59
effectiveness in weight management.
11:01
In fact, as of today, one in eight American adults report having used a GLP-1 drug, and
11:08
projections suggest that by 2030, this number could rise to one in ten.
11:14
Research from Washington University in St.
11:16
Louis, led by Dr.
11:18
Ziyad Al-Aly, has explored the broader health impacts of GLP-1 drugs, revealing some
11:23
fascinating findings.
11:26
The study, which involved over two point four million individuals, evaluated the effects of
11:31
these drugs on one hundred seventy-five different health outcomes.
11:35
Remarkably, the research indicated that GLP-1 drugs could lower the risk of forty-two health
11:41
conditions, nearly a quarter of the outcomes examined.
11:46
Among the significant benefits observed were reductions in the risk of neurocognitive
11:51
disorders, including Alzheimer's disease and dementia.
11:55
This aligns with other studies suggesting that GLP-1 drugs may help reduce brain inflammation
12:02
and improve communication between brain cells, thereby mitigating cognitive decline.
12:08
Such findings are promising, as they point to potential new therapeutic uses for GLP-1 drugs
12:14
beyond their current applications.
12:17
In addition to cognitive benefits, GLP-1 drugs have shown potential in addressing substance
12:23
use disorders, including those related to alcohol, tobacco, cannabis, opioids, and
12:29
stimulants.
12:30
This is thought to be due to the drugs' ability to modulate reward pathways and impulse control
12:35
in the brain.
12:37
Interestingly, the study also noted a reduction in suicidal thoughts and self-harm among users
12:44
of GLP-1 drugs, countering earlier concerns about increased suicidality with these
12:50
medications.
12:52
The cardiovascular benefits of GLP-1 drugs are also noteworthy, with reductions in risks of
12:58
adverse cardiovascular and kidney outcomes, as well as blood clotting issues like deep vein
13:04
thrombosis and pulmonary embolism.
13:07
Additionally, the research highlighted a surprising decrease in the risk of infectious
13:12
diseases, including pneumonia and sepsis.
13:16
This complements other studies suggesting GLP-1 drugs may reduce mortality from cardiovascular
13:23
and infectious causes, such as COVID-19.
13:27
However, despite their potential, GLP-1 drugs are not without risks.
13:33
Common side effects include gastrointestinal issues like nausea, vomiting, and constipation.
13:39
More serious risks identified in the study include low blood pressure, headaches, kidney
13:44
stones, and inflammation of the pancreas and kidneys.
13:48
These findings highlight the need for careful monitoring of individuals taking GLP-1
13:53
medications.
13:55
A significant challenge with GLP-1 drugs is their cost and the high rates of
14:01
discontinuation, often due to side effects or expense.
14:04
When patients stop using these medications, they may experience rapid weight regain, which
14:10
is concerning given that obesity is a chronic condition.
14:14
To be effective long-term, GLP-1 drugs need to be taken consistently, yet they do not address
14:20
the root causes of obesity.
14:23
Ultimately, while GLP-1 drugs show promise in treating a variety of conditions, there are
14:29
still many questions about their long-term safety and effectiveness.
14:34
Ongoing research is crucial to fully understand these drugs and guide their use in clinical
14:39
practice.
14:40
As we continue to explore their potential, it's clear that GLP-1 medications could play a
14:46
significant role in the future of healthcare.
14:50
Today, we're exploring the complex implications of the United States' potential withdrawal from
14:55
the World Health Organization, as articulated by Lawrence Gostin, a renowned expert in global
15:01
health law.
15:02
Gostin argues that leaving the World Health Organization is not only a setback for global
15:06
health but also a significant threat to U.S.
15:09
national security.
15:11
He suggests that the decision could make Americans less safe and secure, while also
15:16
diminishing U.S.
15:17
influence on the global stage.
15:20
Gostin points out that the U.S.
15:22
has historically been a major player within the World Health Organization, exerting significant
15:26
influence through its contributions and leadership.
15:29
This influence is evident in various ways, such as having senior World Health Organization
15:34
staff on loan from the Centers for Disease Control and Prevention and U.S.
15:38
diplomats leading crucial negotiations on World Health Organization regulations and treaties.
15:44
He recalls an instance where U.S.
15:46
Health and Human Services Secretary Xavier Becerra played a pivotal role in negotiations
15:51
at the World Health Assembly, demonstrating the U.S.'s ability to sway international decisions.
15:58
The potential withdrawal from the World Health Organization raises concerns about the loss of
16:03
U.S.
16:04
influence over crucial international agreements, such as the forthcoming pandemic
16:09
treaty.
16:10
This treaty is expected to address pandemic prevention and response, directly impacting
16:16
U.S.
16:16
interests in areas like scientific exchange and equity.
16:20
Gostin warns that if the U.S.
16:22
exits the World Health Organization, it risks allowing adversaries like China to fill the
16:27
void and shape these agreements in ways that may not align with American values and
16:32
interests.
16:33
Gostin emphasizes the importance of the World Health Organization in providing the U.S.
16:39
with vital global health data, which is essential for national security.
16:44
Agencies like the Centers for Disease Control and Prevention and the National Institutes of
16:48
Health rely on this data to make informed decisions about disease outbreaks and research
16:53
initiatives.
16:54
For instance, early access to data from the World Health Organization was instrumental in
16:59
the development of mRNA vaccines during the COVID-19 pandemic.
17:04
He presents a hypothetical scenario where the U.S.
17:08
is the epicenter of an international avian influenza outbreak.
17:12
In such a situation, the U.S.
17:14
would need the World Health Organization's extensive network of laboratories to track the
17:19
virus and develop effective vaccines.
17:23
Without full access to global surveillance data, the U.S.
17:26
would be less prepared, potentially exacerbating the outbreak and leading to a more
17:31
severe pandemic.
17:34
Moreover, the World Health Organization's role in setting healthcare norms and standards, such
17:38
as disease definitions and treatment guidelines, is crucial for maintaining global
17:43
health security.
17:44
The organization also coordinates international responses to major health crises and advocates
17:49
for health equity.
17:51
Gostin argues that without the World Health Organization, the world might not have
17:55
eradicated smallpox or made significant progress towards eradicating polio.
18:00
In conclusion, Gostin identifies three fundamental errors in the U.S.'s potential
18:06
withdrawal from the World Health Organization.
18:08
First, it would create a vacuum that could be filled by China, thereby increasing its
18:13
influence.
18:14
Second, it would weaken the U.S.'s ability to detect and respond to health emergencies.
18:20
Third, it would hinder U.S.
18:22
industries and economy by limiting access to crucial scientific data needed for innovation.
18:28
Gostin stresses that remaining in the World Health Organization is not only beneficial for
18:33
global health but also serves America's vital national interests.
18:39
As we wrap up today's episode, let's delve into the recent executive orders signed by former
18:45
President Donald Trump in the early hours of his second term.
18:49
These orders have sparked considerable discussion, particularly in the realm of
18:54
healthcare policy.
18:55
From rolling back drug pricing policies to limiting gender-affirming care, Trump's
19:00
executive orders have introduced significant changes that could reshape the landscape of
19:06
U.S.
19:06
healthcare.
19:08
One of the most notable aspects of these orders is the reversal of certain drug pricing
19:13
policies.
19:14
During his first term, Trump had implemented measures aimed at reducing prescription drug
19:19
costs, which were seen as a step towards making medications more affordable for Americans.
19:25
However, the recent rollback of these policies has raised concerns about the potential for
19:30
increased drug prices, which could place a heavier financial burden on patients who rely
19:35
on essential medications.
19:38
In addition to changes in drug pricing, Trump's executive orders have also targeted
19:42
gender-affirming care, a critical area of healthcare for the LGBTQ+ community.
19:49
These orders aim to restrict access to gender-affirming treatments, which are vital
19:53
for the mental and physical well-being of transgender individuals.
19:58
This move has been met with opposition from healthcare professionals and advocates who
20:04
emphasize the importance of providing inclusive and supportive care for all patients.
20:10
The broader implications of these executive orders extend beyond individual policies.
20:16
They signal a shift in the administration's approach to healthcare, with potential impacts
20:21
on public health, health equity, and access to care.
20:25
As we navigate these changes, it's crucial to consider the voices of those affected and to
20:31
advocate for policies that promote health and well-being for all.
20:35
In closing, today's discussions have highlighted the intricate connections between
20:40
policy decisions and public health outcomes.
20:43
Whether it's the U.S.'s relationship with the World Health Organization or the impact of
20:47
domestic healthcare policies, these issues underscore the importance of informed
20:52
decision-making and international cooperation in addressing global health challenges.
20:57
Thank you for joining me on Morning Medical with Dr.
20:59
Chow.
21:00
Stay informed, stay healthy, and I'll see you next time.